JP MORGAN/CALL/ABBOTT LABORATORIES/100/0.1/17.01.25 Share Price

Warrant

DE000JL03GD8

Market Closed - Börse Stuttgart 12:44:37 14/06/2024 pm IST
0.92 EUR -6.12% Intraday chart for JP MORGAN/CALL/ABBOTT LABORATORIES/100/0.1/17.01.25
Current month+10.84%
1 month-11.54%
Date Price Change
14/24/14 0.92 -6.12%
13/24/13 0.98 -10.09%
12/24/12 1.09 -1.80%
11/24/11 1.11 -8.26%
10/24/10 1.21 +24.74%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 12:44 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer J.P. Morgan
WKN JL03GD
ISINDE000JL03GD8
Date issued 05/04/2023
Strike 100 $
Maturity 17/01/2025 (215 Days)
Parity 10 : 1
Emission price 1.51
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.42
Lowest since issue 0.75
Spread 0.01
Spread %1.06%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
103.7 USD
Average target price
125.4 USD
Spread / Average Target
+20.92%
Consensus